Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA

Guidance
Cite:

European Centre for Disease Prevention and Control. Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA – An integrated approach. Stockholm: ECDC; 2018.

This guidance provides EU/EEA countries with the latest scientific evidence to help develop, implement, improve, monitor and evaluate national or local HIV, HBV and HCV testing guidelines and programmes. It offers a range of evidence-based options for the design of testing interventions in different settings and populations and supports the variation and integration of testing services.
This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance

Executive summary

The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. 

Increasing testing coverage and uptake, especially for those most at risk, is an essential element of any strategy to eliminate HIV, HBV and HCV in the European Union and European Economic Area (EU/EEA). In order to interrupt existing transmission chains and prevent further infections, Europe needs a stronger focus on working closely with vulnerable populations. This will improve efforts to identify those who are infected but not diagnosed and link them to appropriate healthcare services.

 

Read the full report

Read more on the ECDC website